These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 23799547

  • 1. Rosuvastatin prevents pressure overload‑induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats.
    Xu X, Zhang L, Liang J.
    Mol Med Rep; 2013 Aug; 8(2):385-92. PubMed ID: 23799547
    [Abstract] [Full Text] [Related]

  • 2. Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy via suppression of Gh.
    Choi EY, Chang W, Lim S, Song BW, Cha MJ, Kim HJ, Choi E, Jang Y, Chung N, Hwang KC.
    Eur J Pharmacol; 2010 Feb 10; 627(1-3):56-62. PubMed ID: 19883640
    [Abstract] [Full Text] [Related]

  • 3. Rosuvastatin attenuates atherosclerosis in rats via activation of scavenger receptor class B type I.
    Li Y, Wang Q, Zhou J, Xu Q, Chu X, Sun T, Liu X, Cai S.
    Eur J Pharmacol; 2014 Jan 15; 723():23-8. PubMed ID: 24333476
    [Abstract] [Full Text] [Related]

  • 4. Effect of combined treatment with rosuvastatin and protein kinase Cβ2 inhibitor on angiogenesis following myocardial infarction in diabetic rats.
    Huang D, Wang FB, Guo M, Li S, Yan ML, Yu T, Wei M, Li JB.
    Int J Mol Med; 2015 Mar 15; 35(3):829-38. PubMed ID: 25524396
    [Abstract] [Full Text] [Related]

  • 5. Salvianolic Acid B Alleviates Heart Failure by Inactivating ERK1/2/GATA4 Signaling Pathway after Pressure Overload in Mice.
    Yu J, Chen R, Tan Y, Wu J, Qi J, Zhang M, Gu W.
    PLoS One; 2016 Mar 15; 11(11):e0166560. PubMed ID: 27893819
    [Abstract] [Full Text] [Related]

  • 6. [Rosuvastatin enhances the protective effects of ischemic postconditioning on myocardial ischaemia-reperfusion injury in type 2 diabetic rat].
    CAI W, FANG J, CHEN ZY, LIN YL, WU LM, CHEN LL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep 15; 38(9):814-8. PubMed ID: 21092651
    [Abstract] [Full Text] [Related]

  • 7. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
    Meng R, Pei Z, Zhang A, Zhou Y, Cai X, Chen B, Liu G, Mai W, Wei J, Dong Y.
    Arch Biochem Biophys; 2011 Jul 15; 511(1-2):1-7. PubMed ID: 21530483
    [Abstract] [Full Text] [Related]

  • 8. Relation of Cardiotrophin-1 (CT-1) and cardiac transcription factor GATA4 expression in rat's cardiac myocytes hypertrophy and apoptosis.
    He-nan Z, Yan W, Miao-na J, Cai-hua Z, Shen L, Yu-jie J.
    Pathol Res Pract; 2009 Jul 15; 205(9):615-25. PubMed ID: 19327894
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-26a protects against cardiac hypertrophy via inhibiting GATA4 in rat model and cultured cardiomyocytes.
    Liu Y, Wang Z, Xiao W.
    Mol Med Rep; 2016 Sep 15; 14(3):2860-6. PubMed ID: 27485101
    [Abstract] [Full Text] [Related]

  • 10. Improved cardiac performance by rosuvastatin is associated with attenuations in both myocardial tumor necrosis factor-alpha and p38 MAP kinase activity in rats after myocardial infarction.
    Xu Y, Tang T, Ding Y, Yao R, Xie J, Liao M, Xiao H, Chen Y, Yu X, Fu M, Liao Y, Zhao G, Cheng X.
    Am J Med Sci; 2010 Aug 15; 340(2):121-7. PubMed ID: 20588182
    [Abstract] [Full Text] [Related]

  • 11. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.
    Rose M, Balakumar P, Singh M.
    Pharmacology; 2007 Aug 15; 80(2-3):177-84. PubMed ID: 17570955
    [Abstract] [Full Text] [Related]

  • 12. Multiple signalling pathways underlie the protective effect of levosimendan in cardiac myocytes.
    Markou T, Makridou Z, Galatou E, Lazou A.
    Eur J Pharmacol; 2011 Sep 30; 667(1-3):298-305. PubMed ID: 21664904
    [Abstract] [Full Text] [Related]

  • 13. Effect of rosuvastatin on insulin sensitivity in an animal model of insulin resistance: evidence for statin-induced hepatic insulin sensitization.
    Naples M, Federico LM, Xu E, Nelken J, Adeli K.
    Atherosclerosis; 2008 May 30; 198(1):94-103. PubMed ID: 18093597
    [Abstract] [Full Text] [Related]

  • 14. [Sympathetic nerve in rat with pressure overload left ventricular hypertrophy].
    Liao Y, Qu XF, Liu L, Dong XM, Yin DC.
    Zhonghua Yi Xue Za Zhi; 2009 Sep 15; 89(34):2412-5. PubMed ID: 20137696
    [Abstract] [Full Text] [Related]

  • 15. Regulatory T cells contribute to rosuvastatin-induced cardioprotection against ischemia-reperfusion injury.
    Ke D, Fang J, Fan L, Chen Z, Chen L.
    Coron Artery Dis; 2013 Jun 15; 24(4):334-41. PubMed ID: 23531479
    [Abstract] [Full Text] [Related]

  • 16. FAK-related nonkinase attenuates hypertrophy induced by angiotensin-II in cultured neonatal rat cardiac myocytes.
    Qin J, Liu ZX.
    Acta Pharmacol Sin; 2006 Sep 15; 27(9):1159-64. PubMed ID: 16923336
    [Abstract] [Full Text] [Related]

  • 17. Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways.
    Zhang Z, Li S, Cui M, Gao X, Sun D, Qin X, Narsinh K, Li C, Jia H, Li C, Han Y, Wang H, Cao F.
    Basic Res Cardiol; 2013 Mar 15; 108(2):333. PubMed ID: 23386286
    [Abstract] [Full Text] [Related]

  • 18. Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability.
    Schäfer A, Fraccarollo D, Eigenthaler M, Tas P, Firnschild A, Frantz S, Ertl G, Bauersachs J.
    Arterioscler Thromb Vasc Biol; 2005 May 15; 25(5):1071-7. PubMed ID: 15761193
    [Abstract] [Full Text] [Related]

  • 19. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
    Kemi OJ, Ceci M, Wisloff U, Grimaldi S, Gallo P, Smith GL, Condorelli G, Ellingsen O.
    J Cell Physiol; 2008 Feb 15; 214(2):316-21. PubMed ID: 17941081
    [Abstract] [Full Text] [Related]

  • 20. Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy.
    Custodis F, Eberl M, Kilter H, Böhm M, Laufs U.
    Cardiovasc Res; 2006 Jul 15; 71(2):342-51. PubMed ID: 16698001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.